DEA's Approach To Marijuana Rescheduling Is Creating Deep Uncertainty For Regulators, Patients And Market Operators (Op-Ed)
Key Takeaway
"Supply chains in many states will not have enough cultivators, manufacturers and dispensaries to support a viable supply chain in either the DEA market or the state-only market." By Gillian L. Schauer, Cannabis Regulators Association Late last month, the Drug Enforcement Administration (DEA) took three significant actions related to federal medical marijuana rescheduling: issuing guidance
What This Means for Cannabis Businesses
Tax developments like this directly impact the bottom line for every cannabis operator. With Section 280E creating effective tax rates above 70% for many businesses, any shift in federal tax policy - whether through rescheduling, court rulings, or IRS guidance - can mean the difference between profitability and closure. Cannabis business owners should work closely with a specialized CPA to understand how these changes affect their specific situation.
Oregon Cannabis Market Overview
Oregon has a well-established cannabis market with publicly available license data. The state is known for competitive pricing and a large number of craft producers. The state has approximately 2,000 active cannabis licenses and 9 licensed testing laboratories. There are 49 cannabis professionals serving Oregon businesses on our directory, including CPAs, attorneys, and compliance consultants.
Related News
Cannabis MSOs Owe $1.6 Billion in Unpaid 280E Taxes as IRS Fights Back
IRS Disputes Cannabis Company's Challenge to 280E in Tax Court
Michigan Cannabis Sales Fall to Lowest Level in Two Years Under New Wholesale Tax
Congressional Research Service Questions Constitutionality of Cannabis Tax Section 280E
This analysis is based on reporting by Marijuana Moment. Read the original article. CannaBizGuide provides original commentary and analysis - this is not legal or tax advice.